Ketamine powder refers to any type of ketamine that is in a powdered substance. The term itself does not tell you what a substance contains, how strong it is, or where it came from. The presence of powder does not prove it is ketamine.
There are medical applications for Ketamine. It is used as an anaesthetic and to make a person numb, and esketamine is licensed in the UK for some people with treatment-resistant depression. Meanwhile, ketamine is at the same time a Class B unrestricted substance in the United Kingdom. In 2026 the Advisory Council on the Misuse of Drugs (ACMD) again considered the harms and decided that there was no need to re-classify broken down as a Class B drug.
What does “ketamine powder” mean?
Over time, “ketamine powder” typically describes the dry solid form of Ketamine, not a solution that has been made for medical use. It is a slang term for the informal drug market and online conversations. Not a medical product name in its own right.
This distinction is important because the term ketamine can be used to designate a medical drug, or it can be a drug that is not part of the health care system, and is unknown to the user. A medical product fulfills controlled manufacturing, has known ingredients and fulfills defined qualities and strength in its pharmaceutical manufacturing. These may not be present in an unknown powder.
Ketamine is considered a medicine by the ACMD according to their description. It is also under the control of drugs in the UK.
If you’re interested in the bigger picture of health, the linked Ketamine: Medical Uses, Risks and UK Law pillar page will provide further information about the drug and its legal status.
Is powder a pharmaceutical form?
Licensed medicines for ketamine are not often given as powder. Medical ketamine products may be provided in pre-formulated pharmaceutical products such as solutions (clinical use). The specific formulation will be dependent on the drug in question, the use and how the drug is indicated. Ketamine may also be purchased in authorised veterinary medicines. For example, authorised veterinary medicines with ketamine hydrochloride are listed on GOV.UK.
The case of Esketamine is a standalone case. There is a preparation of esketamine, which has been made available in the UK for treatment-resistant depression. It is not simply the same thing as an unidentified powder described as ketamine.
This is why ‘powder’ should not be interpreted as a sign that a drug is pharmaceutical ketamine. A substance may appear the same as a medicine, but be different in quality, strength or contents.
What colour can ketamine powder appear to be?
Ketamine powder may be white or off-white but colour is not an indicator of what the drug may be. White powder is not necessarily ketamine. There are other substances with a similar appearance. Even when they can see that a sample is similar to some that he or she has encountered before, they can’t prove its identity.
Differences in pharmaceutical materials also may exist between their appearances, depending upon their formulation, manufacturing process and other ingredients. Colour, texture and the apparent fineness for an unknown powder doesn’t give an accurate indication of what’s actually there.
This is crucial in harm reduction. But the visual appearance, if misleading, leads to false sense of security. When you are dealing with a substance that appears to be the same you may not know what it is or its exact concentration.
Why colour and texture cannot confirm identity
The look of a substance is just some of its physical properties. It does not provide a complete chemical identification. There can be two substances that are similar in appearance. The appearance of the same substance can differ due its shape or chemical composition or other substances that may be involved, which depends on the substance’s formulation. This significantly narrows the possibilities of visually describing powders outside of a controlled medical supply chain.
Checking for ketamine is not the only concern with a powder. The strength of an unknown sample may be very weak, or it could contain something other than the sample. The ACMD’s 2026 review is focused on the negative impacts of ketamine use and the broader dangers of drug misuse.
For this reason, colour, texture, and appearance alone should not be used to support a claim. The following information is not intended to give methods for testing or making unknown powders.
Powder vs crystal terminology
Sometimes drugs are referred to as “powder”, “crystal” or “crystalline”. Most of the words found in these categories refer to physical characteristics. They are not characteristics which define the identity or quality of a substance.
The term “crystal” also may give the impression that the product is more sophisticated or pure. That’s not the case just because it looks like that. But, in a medical context, it is the fact that a substance may be powdery or crystalline that is important. The ingredient, the formulation, the strength, and the manufacturing quality and approved use are what’s important, not the medicine itself.
This difference would be helpful for any information they read online. When describing an unknown product, be cautious of the informal description being more certain than the evidence presented.
Claims such as “pure” or “pharmaceutical grade”
The terms “pure”, “clean” and “pharmaceutical grade” can be reassuring. But a label or one that has been claimed on the Internet does not guarantee a pharmaceutical quality. Medicinal products are produced within regulated systems. There are special requirements for identity, composition and quality. An unknown powder lying outside this system shouldn’t be assumed to be of pharmaceutical grade just because someone says it is.
The same applies to claims about a particular percentage of purity. Any number printed on food packaging or provided in an online listing is not evidence of what is in a substance without proper documentation from a reliable source. This distinction is especially important since there is a legitimate medical use for ketamine. A real medicine and unknown powder should not be used interchangeably.
Why unknown concentration matters
If you know a substance is called Ketamine, it does not automatically mean what the concentration is. Medical products are supplied with defined strengths and are made to meet pharmaceutical standards. If an unknown powder is not exactly the same, then it does not necessarily give the same certainty. The quantity of active substance might not be known and there may be other substances as well.
This uncertainty is important since ketamine can have potentially strong effects on the central nervous system. The ACMD’s updated review discusses acute toxicity as well as longer-term harms linked with repeated or high-dose misuse. It also recognises that the use of other drugs might affect some acute harms.
The principle of harm reduction is quite simple, however: appearance and informal labels don’t provide indication of strength or safety.
Medical ketamine vs unknown powder
Ketamine is a legit drug in medicine. A clinician can recognize which medicine it is, understand its formulation and strength, and utilize it for a suitable medicine use. Although it may be helpful to mention that Ketamine continues to be an integral part of the treatment of many illnesses and esketamine remains a licensed treatment for treatment resistant depression.
The powder is different when it is unknown. The presence does not guarantee the contents, concentration, manufacturing qualities or medical appropriateness. The legal status also plays a part. Ketamine is now a class B controlled substance in the UK. Ketamine is included on the list of Class B drugs on GOV.UK and was recommended to stay in this classification by the 2026 ACMD review.
Knowing the difference between a regulated medicine and an unknown powder is important to avoid one of the most common errors, matching the legitimate medical uses of ketamine to other substances.
References
https://www.gov.uk/government/news/acmd-announces-decision-on-the-classification-of-ketamine
https://www.gov.uk/penalties-drug-possession-dealing
Evidence last checked: 21 September 2026
